{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:14:35Z","timestamp":1772892875773,"version":"3.50.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/17746-3"],"award-info":[{"award-number":["2016\/17746-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ALANA USA Foundation","award":["124124"],"award-info":[{"award-number":["124124"]}]},{"name":"Awakening Angels Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mounting evidence implicates dysfunctional GABA<jats:sub>A<\/jats:sub>R-mediated neurotransmission as one of the underlying causes of learning and memory deficits observed in the Ts65Dn mouse model of Down syndrome (DS). The specific origin and nature of such dysfunction is still under investigation, which is an issue with practical consequences to preclinical and clinical research, as well as to the care of individuals with DS and anxiety disorder or those experiencing seizures in emergency room settings. Here, we investigated the effects of GABA<jats:sub>A<\/jats:sub>R positive allosteric modulation (PAM) by diazepam on brain activity, synaptic plasticity, and behavior in Ts65Dn mice. We found Ts65Dn mice to be less sensitive to diazepam, as assessed by electroencephalography, long-term potentiation, and elevated plus-maze. Still, diazepam pre-treatment displayed typical effectiveness in reducing susceptibility and severity to picrotoxin-induced seizures in Ts65Dn mice. These findings fill an important gap in the understanding of GABAergic function in a key model of DS.<\/jats:p>","DOI":"10.1038\/s41598-021-89011-y","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T10:04:32Z","timestamp":1620122672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome"],"prefix":"10.1038","volume":"11","author":[{"given":"Daniella B.","family":"Victorino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J. L. L.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonah J.","family":"Scott-McKean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Barker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa R.","family":"Stasko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla A.","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto C. S.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"89011_CR1","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT Mai","year":"2019","unstructured":"Mai, C. T. et al. National population-based estimates for major birth defects, 2010\u20132014. Birth Defects Res. 111, 1420\u20131435 (2019).","journal-title":"Birth Defects Res."},{"key":"89011_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3390\/brainsci8120205","volume":"8","author":"IA Basten","year":"2018","unstructured":"Basten, I.A., et al. On the design of broad-based neuropsychological test batteries to assess the cognitive abilities of individuals with down syndrome in the context of clinical trials. Brain Sci. 8, 205. https:\/\/doi.org\/10.3390\/brainsci8120205 (2018).","journal-title":"Brain Sci"},{"key":"89011_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1034\/j.1601-183X.2003.00026.x","volume":"2","author":"L Nadel","year":"2003","unstructured":"Nadel, L. Down\u2019s syndrome: A genetic disorder in biobehavioral perspective. Genes Brain Behav. 2, 156\u2013166 (2003).","journal-title":"Genes Brain Behav."},{"key":"89011_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.nrl.2014.12.008","volume":"32","author":"JS Aller-Alvarez","year":"2017","unstructured":"Aller-Alvarez, J. S. et al. Myoclonic epilepsy in Down syndrome and Alzheimer disease. Neurologia 32, 69\u201373 (2017).","journal-title":"Neurologia"},{"key":"89011_CR5","doi-asserted-by":"publisher","first-page":"e710","DOI":"10.1097\/MD.0000000000000710","volume":"94","author":"KR Foley","year":"2015","unstructured":"Foley, K. R. et al. Patterns of depressive symptoms and social relating behaviors differ over time from other behavioral domains for young people with Down syndrome. Medicine (Baltimore) 94, e710 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"89011_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2015.03.016","volume":"29","author":"J Robertson","year":"2015","unstructured":"Robertson, J., Hatton, C., Emerson, E. & Baines, S. Prevalence of epilepsy among people with intellectual disabilities: A systematic review. Seizure 29, 46\u201362 (2015).","journal-title":"Seizure"},{"key":"89011_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/YPG.0b013e32835fe426","volume":"23","author":"S Vicari","year":"2013","unstructured":"Vicari, S., Pontillo, M. & Armando, M. Neurodevelopmental and psychiatric issues in Down\u2019s syndrome: Assessment and intervention. Psychiatr. Genet. 23, 95\u2013107 (2013).","journal-title":"Psychiatr. Genet."},{"key":"89011_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2011.0415","volume":"13","author":"R Arya","year":"2011","unstructured":"Arya, R., Kabra, M. & Gulati, S. Epilepsy in children with Down syndrome. Epileptic Disord. 13, 1\u20137 (2011).","journal-title":"Epileptic Disord."},{"key":"89011_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1684\/epd.2011.0426","volume":"13","author":"A Vignoli","year":"2011","unstructured":"Vignoli, A. et al. Epilepsy in adult patients with Down syndrome: A clinical-video EEG study. Epileptic Disord. 13, 125\u2013132 (2011).","journal-title":"Epileptic Disord."},{"key":"89011_CR10","first-page":"173","volume":"13","author":"MJ Tasse","year":"2016","unstructured":"Tasse, M. J. et al. Psychiatric conditions prevalent among adults with down syndrome. J. Policy Pract. Intel. 13, 173\u2013180 (2016).","journal-title":"J. Policy Pract. Intel."},{"key":"89011_CR11","doi-asserted-by":"publisher","first-page":"8153","DOI":"10.1523\/JNEUROSCI.1766-04.2004","volume":"24","author":"AM Kleschevnikov","year":"2004","unstructured":"Kleschevnikov, A. M. et al. Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J. Neurosci. 24, 8153\u20138160 (2004).","journal-title":"J. Neurosci."},{"key":"89011_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neulet.2005.03.031","volume":"382","author":"AC Costa","year":"2005","unstructured":"Costa, A. C. & Grybko, M. J. Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome. Neurosci. Lett. 382, 317\u2013322 (2005).","journal-title":"Neurosci. Lett."},{"key":"89011_CR13","doi-asserted-by":"publisher","first-page":"9235796","DOI":"10.1155\/2018\/9235796","volume":"2018","author":"JJ Scott-McKean","year":"2018","unstructured":"Scott-McKean, J. J. et al. Pharmacological modulation of three modalities of CA1 hippocampal long-term potentiation in the Ts65Dn mouse model of down syndrome. Neural. Plast. 2018, 9235796 (2018).","journal-title":"Neural. Plast."},{"key":"89011_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nn1860","volume":"10","author":"F Fernandez","year":"2007","unstructured":"Fernandez, F. et al. Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat. Neurosci. 10, 411\u2013413 (2007).","journal-title":"Nat. Neurosci."},{"key":"89011_CR15","unstructured":"Monash University. Down syndrome trial may hold key to learning. http:\/\/compose21.com\/study.htm (2013)."},{"key":"89011_CR16","unstructured":"NCT01436955. A study of RG1662 in individuals with down syndrome. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01436955 (2011)."},{"key":"89011_CR17","unstructured":"NCT02024789. A multi-center, randomized, double-blind, placebo-controlled phase 2 study of the efficacy, safety and tolerability of Rg1662 in adults and adolescents with down syndrome (CLEMATIS). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02024789 (2013)."},{"key":"89011_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nm.3827","volume":"21","author":"G Deidda","year":"2015","unstructured":"Deidda, G. et al. Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome. Nat. Med. 21, 318\u2013326 (2015).","journal-title":"Nat. Med."},{"key":"89011_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","volume":"39","author":"E Sigel","year":"2018","unstructured":"Sigel, E. & Ernst, M. The benzodiazepine binding sites of GABAA receptors. Trends Pharmacol. Sci. 39, 659\u2013671 (2018).","journal-title":"Trends Pharmacol. Sci."},{"key":"89011_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/nm.3836","volume":"21","author":"AC Costa","year":"2015","unstructured":"Costa, A. C. Intracellular chloride accumulation: A possible mechanism for cognitive deficits in Down syndrome. Nat. Med. 21, 312\u2013313 (2015).","journal-title":"Nat. Med."},{"key":"89011_CR21","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.2147\/NDT.S210613","volume":"15","author":"JH Miles","year":"2019","unstructured":"Miles, J. H., Takahashi, N., Muckerman, J., Nowell, K. P. & Ithman, M. Catatonia in Down syndrome: Systematic approach to diagnosis, treatment and outcome assessment based on a case series of seven patients. Neuropsychiatr. Dis. Treat 15, 2723\u20132741 (2019).","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"89011_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.neubiorev.2018.05.001","volume":"90","author":"JT Schulte","year":"2018","unstructured":"Schulte, J. T., Wierenga, C. J. & Bruining, H. Chloride transporters and GABA polarity in developmental, neurological and psychiatric conditions. Neurosci. Biobehav. Rev. 90, 260\u2013271 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"89011_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0304-3940(00)01496-8","volume":"293","author":"ML Jongsma","year":"2000","unstructured":"Jongsma, M. L. et al. The influence of diazepam on the electroencephalogram-evoked potential interrelation in rats. Neurosci. Lett. 293, 83\u201386 (2000).","journal-title":"Neurosci. Lett."},{"key":"89011_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.neuropharm.2004.03.017","volume":"47","author":"H van Lier","year":"2004","unstructured":"van Lier, H., Drinkenburg, W. H., van Eeten, Y. J. & Coenen, A. M. Effects of diazepam and zolpidem on EEG beta frequencies are behavior-specific in rats. Neuropharmacology 47, 163\u2013174 (2004).","journal-title":"Neuropharmacology"},{"key":"89011_CR25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/155005940603700205","volume":"37","author":"B Saletu","year":"2006","unstructured":"Saletu, B., Anderer, P. & Saletu-Zyhlarz, G. M. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Clin. EEG Neurosci. 37, 66\u201380 (2006).","journal-title":"Clin. EEG Neurosci."},{"key":"89011_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/0269881107077733","volume":"21","author":"C Gilles","year":"2007","unstructured":"Gilles, C. & Luthringer, R. Pharmacological models in healthy volunteers: Their use in the clinical development of psychotropic drugs. J. Psychopharmacol. 21, 272\u2013282 (2007).","journal-title":"J. Psychopharmacol."},{"key":"89011_CR27","unstructured":"Center for Drug Evaluation and Research (CDER). Guidance for industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. https:\/\/www.fda.gov\/media\/72309\/download (2005)."},{"key":"89011_CR28","unstructured":"Hoffmann-La Roche. Valium. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2016\/013263s094lbl.pdf (2016)."},{"key":"89011_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrn2979","volume":"12","author":"J Fell","year":"2011","unstructured":"Fell, J. & Axmacher, N. The role of phase synchronization in memory processes. Nat. Rev. Neurosci. 12, 105\u2013118 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"89011_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","volume":"95","author":"J Van Erum","year":"2019","unstructured":"Van Erum, J., Van Dam, D. & De Deyn, P. P. PTZ-induced seizures in mice require a revised Racine scale. Epilepsy Behav. 95, 51\u201355 (2019).","journal-title":"Epilepsy Behav."},{"key":"89011_CR31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/(SICI)1098-1063(1998)8:3<289::AID-HIPO10>3.0.CO;2-X","volume":"8","author":"CA Chapman","year":"1998","unstructured":"Chapman, C. A., Perez, Y. & Lacaille, J. C. Effects of GABA(A) inhibition on the expression of long-term potentiation in CA1 pyramidal cells are dependent on tetanization parameters. Hippocampus 8, 289\u2013298 (1998).","journal-title":"Hippocampus"},{"key":"89011_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/301603a0","volume":"301","author":"H Wigstrom","year":"1983","unstructured":"Wigstrom, H. & Gustafsson, B. Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature 301, 603\u2013604 (1983).","journal-title":"Nature"},{"key":"89011_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/hup.408","volume":"17","author":"E Dailly","year":"2002","unstructured":"Dailly, E., Hascoet, M., Colombel, M. C., Jolliet, P. & Bourin, M. Relationship between cerebral pharmacokinetics and anxiolytic activity of diazepam and its active metabolites after a single intra-peritoneal administration of diazepam in mice. Hum. Psychopharmacol. 17, 239\u2013245 (2002).","journal-title":"Hum. Psychopharmacol."},{"key":"89011_CR34","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.3390\/ijms20143486","volume":"20","author":"JI Hofmann","year":"2019","unstructured":"Hofmann, J.I., Schwarz, C., Rudolph, U., Antkowiak, B. Effects of diazepam on low-frequency and high-frequency electrocortical gamma-power mediated by alpha1- and alpha2-GABAA receptors. Int. J. Mol. Sci. 20, 3486. https:\/\/doi.org\/10.3390\/ijms20143486 (2019).","journal-title":"Int. J. Mol. Sci"},{"key":"89011_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1152\/jn.00539.2013","volume":"113","author":"EP Christian","year":"2015","unstructured":"Christian, E. P. et al. EEG-beta\/gamma spectral power elevation in rat: a translatable biomarker elicited by GABA(Aalpha2\/3)-positive allosteric modulators at nonsedating anxiolytic doses. J. Neurophysiol. 113, 116\u2013131 (2015).","journal-title":"J. Neurophysiol."},{"key":"89011_CR36","first-page":"65","volume":"17","author":"CM Rijn","year":"1995","unstructured":"Rijn, C. M., Jongsma, M. Chronic effects of diazepam on the spectral content of the rat EEG. Neurosci. Res. Commun. 17, 65\u201369 (1995).","journal-title":"Neurosci. Res. Commun."},{"key":"89011_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.neuroimage.2005.02.008","volume":"26","author":"O Jensen","year":"2005","unstructured":"Jensen, O. et al. On the human sensorimotor-cortex beta rhythm: Sources and modeling. Neuroimage 26, 347\u2013355 (2005).","journal-title":"Neuroimage"},{"key":"89011_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-neuro-062111-150444","volume":"35","author":"G Buzsaki","year":"2012","unstructured":"Buzsaki, G. & Wang, X. J. Mechanisms of gamma oscillations. Annu. Rev. Neurosci. 35, 203\u2013225 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"89011_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0167-8760(00)00173-2","volume":"38","author":"MA Whittington","year":"2000","unstructured":"Whittington, M. A., Traub, R. D., Kopell, N., Ermentrout, B. & Buhl, E. H. Inhibition-based rhythms: Experimental and mathematical observations on network dynamics. Int. J. Psychophysiol. 38, 315\u2013336 (2000).","journal-title":"Int. J. Psychophysiol."},{"key":"89011_CR40","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/sj.bjp.0702113","volume":"125","author":"HJ Faulkner","year":"1998","unstructured":"Faulkner, H. J., Traub, R. D. & Whittington, M. A. Disruption of synchronous gamma oscillations in the rat hippocampal slice: A common mechanism of anaesthetic drug action. Br. J. Pharmacol. 125, 483\u2013492 (1998).","journal-title":"Br. J. Pharmacol."},{"key":"89011_CR41","doi-asserted-by":"publisher","first-page":"e12655","DOI":"10.14814\/phy12652.12655","volume":"3","author":"NP Cramer","year":"2015","unstructured":"Cramer, N.P., Xu, X., T, F. H., Galdzicki, Z. Altered intrinsic and network properties of neocortical neurons in the Ts65Dn mouse model of down syndrome. Physiol. Rep. 3, e12655.  https:\/\/doi.org\/10.14814\/phy12652.12655 (2015).","journal-title":"Physiol. Rep"},{"key":"89011_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1073\/pnas.0605643104","volume":"104","author":"A Luczak","year":"2007","unstructured":"Luczak, A., Bartho, P., Marguet, S. L., Buzsaki, G. & Harris, K. D. Sequential structure of neocortical spontaneous activity in vivo. Proc. Natl. Acad. Sci. USA 104, 347\u2013352 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"89011_CR43","first-page":"6","volume":"9","author":"T Kuki","year":"2015","unstructured":"Kuki, T. et al. Contribution of parvalbumin and somatostatin-expressing GABAergic neurons to slow oscillations and the balance in beta-gamma oscillations across cortical layers. Front. Neural Circ. 9, 6 (2015).","journal-title":"Front. Neural Circ."},{"key":"89011_CR44","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1126\/science.1208884","volume":"334","author":"KN Brown","year":"2011","unstructured":"Brown, K. N. et al. Clonal production and organization of inhibitory interneurons in the neocortex. Science 334, 480\u2013486 (2011).","journal-title":"Science"},{"key":"89011_CR45","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1152\/jn.00178.2010","volume":"104","author":"MV Sanchez-Vives","year":"2010","unstructured":"Sanchez-Vives, M. V. et al. Inhibitory modulation of cortical up states. J. Neurophysiol. 104, 1314\u20131324 (2010).","journal-title":"J. Neurophysiol."},{"key":"89011_CR46","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nn.2600","volume":"13","author":"L Chakrabarti","year":"2010","unstructured":"Chakrabarti, L. et al. Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat. Neurosci. 13, 927\u2013934 (2010).","journal-title":"Nat. Neurosci."},{"key":"89011_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00702-010-0376-9","volume":"117","author":"D Perez-Cremades","year":"2010","unstructured":"Perez-Cremades, D. et al. Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down\u2019s syndrome. J. Neural. Transm. (Vienna) 117, 445\u2013455 (2010).","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"89011_CR48","doi-asserted-by":"publisher","first-page":"e58731","DOI":"10.57554\/eLife.58731","volume":"9","author":"J Zorrilla de San Martin","year":"2020","unstructured":"Zorrilla de San Martin, J. et al. Alterations of specific cortical GABAergic circuits underlie abnormal network activity in a mouse model of Down syndrome. Elife 9, e58731 https:\/\/doi.org\/10.57554\/eLife.58731 (2020).","journal-title":"Elife"},{"key":"89011_CR49","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nrn3314","volume":"13","author":"M Dierssen","year":"2012","unstructured":"Dierssen, M. Down syndrome: The brain in trisomic mode. Nat. Rev. Neurosci. 13, 844\u2013858 (2012).","journal-title":"Nat. Rev. Neurosci."},{"key":"89011_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.03.005","volume":"115","author":"LV Lysenko","year":"2018","unstructured":"Lysenko, L. V. et al. Developmental excitatory-to-inhibitory GABA polarity switch is delayed in Ts65Dn mice, a genetic model of Down syndrome. Neurobiol. Dis. 115, 1\u20138 (2018).","journal-title":"Neurobiol. Dis."},{"key":"89011_CR51","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/cercor\/bhm160","volume":"18","author":"AB Ali","year":"2008","unstructured":"Ali, A. B. & Thomson, A. M. Synaptic alpha 5 subunit-containing GABAA receptors mediate IPSPs elicited by dendrite-preferring cells in rat neocortex. Cereb. Cortex 18, 1260\u20131271 (2008).","journal-title":"Cereb. Cortex"},{"key":"89011_CR52","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0269881111405366","volume":"25","author":"J Braudeau","year":"2011","unstructured":"Braudeau, J. et al. Specific targeting of the GABA-A receptor alpha5 subtype by a selective inverse agonist restores cognitive deficits in Down syndrome mice. J. Psychopharmacol. 25, 1030\u20131042 (2011).","journal-title":"J. Psychopharmacol."},{"key":"89011_CR53","doi-asserted-by":"publisher","first-page":"5210","DOI":"10.1523\/JNEUROSCI.2723-18.2019","volume":"39","author":"JM Schulz","year":"2019","unstructured":"Schulz, J. M., Knoflach, F., Hernandez, M. C. & Bischofberger, J. Enhanced dendritic inhibition and impaired NMDAR activation in a mouse model of Down Syndrome. J. Neurosci. 39, 5210\u20135221 (2019).","journal-title":"J. Neurosci."},{"key":"89011_CR54","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/bph.14903","volume":"177","author":"A Duchon","year":"2020","unstructured":"Duchon, A. et al. Long-lasting correction of in vivo LTP and cognitive deficits of mice modelling Down syndrome with an alpha5-selective GABAA inverse agonist. Br. J. Pharmacol. 177, 1106\u20131118 (2020).","journal-title":"Br. J. Pharmacol."},{"issue":"Pt 2","key":"89011_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neubiorev.2013.12.008","volume":"46","author":"C Martinez-Cue","year":"2014","unstructured":"Martinez-Cue, C., Delatour, B. & Potier, M. C. Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA alpha5-selective inverse agonists. Neurosci. Biobehav. Rev. 46(Pt 2), 218\u2013227 (2014).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"89011_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tics.2010.09.001","volume":"14","author":"RT Canolty","year":"2010","unstructured":"Canolty, R. T. & Knight, R. T. The functional role of cross-frequency coupling. Trends Cogn. Sci. 14, 506\u2013515 (2010).","journal-title":"Trends Cogn. Sci."},{"key":"89011_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.tics.2007.05.003","volume":"11","author":"O Jensen","year":"2007","unstructured":"Jensen, O. & Colgin, L. L. Cross-frequency coupling between neuronal oscillations. Trends Cogn. Sci. 11, 267\u2013269 (2007).","journal-title":"Trends Cogn. Sci."},{"key":"89011_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuropharm.2012.09.014","volume":"65","author":"C Scheffzuk","year":"2013","unstructured":"Scheffzuk, C. et al. Global slowing of network oscillations in mouse neocortex by diazepam. Neuropharmacology 65, 123\u2013133 (2013).","journal-title":"Neuropharmacology"},{"key":"89011_CR59","doi-asserted-by":"publisher","first-page":"11788","DOI":"10.1073\/pnas.1921314117","volume":"117","author":"M Alemany-Gonzalez","year":"2020","unstructured":"Alemany-Gonzalez, M. et al. Prefrontal-hippocampal functional connectivity encodes recognition memory and is impaired in intellectual disability. Proc. Natl. Acad. Sci. USA 117, 11788\u201311798 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"89011_CR60","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","volume":"92","author":"RG Lister","year":"1987","unstructured":"Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180\u2013185 (1987).","journal-title":"Psychopharmacology"},{"key":"89011_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/BF02361154","volume":"26","author":"ME Coussons-Read","year":"1996","unstructured":"Coussons-Read, M. E. & Crnic, L. S. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: Altered behavior in the elevated plus maze and open field. Behav. Genet. 26, 7\u201313 (1996).","journal-title":"Behav. Genet."},{"key":"89011_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11065-006-9008-4","volume":"16","author":"S Vicari","year":"2006","unstructured":"Vicari, S. & Carlesimo, G. A. Short-term memory deficits are not uniform in Down and Williams syndromes. Neuropsychol. Rev. 16, 87\u201394 (2006).","journal-title":"Neuropsychol. Rev."},{"key":"89011_CR63","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.bbr.2005.11.020","volume":"168","author":"NC Dowdy-Sanders","year":"2006","unstructured":"Dowdy-Sanders, N. C. & Wenger, G. R. Working memory in the Ts65Dn mouse, a model for Down syndrome. Behav. Brain Res. 168, 349\u2013352 (2006).","journal-title":"Behav. Brain Res."},{"key":"89011_CR64","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1037\/0735-7044.118.6.1196","volume":"118","author":"LL Driscoll","year":"2004","unstructured":"Driscoll, L. L. et al. Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: A mouse model of Down syndrome and Alzheimer\u2019s disease. Behav. Neurosci. 118, 1196\u20131205 (2004).","journal-title":"Behav. Neurosci."},{"key":"89011_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0166-4328(02)00275-9","volume":"138","author":"CL Hunter","year":"2003","unstructured":"Hunter, C. L., Bimonte, H. A. & Granholm, A. C. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: Age-related impairments in working and reference memory. Behav. Brain Res. 138, 121\u2013131 (2003).","journal-title":"Behav. Brain Res."},{"key":"89011_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0149-7634(01)00009-4","volume":"25","author":"DC Blanchard","year":"2001","unstructured":"Blanchard, D. C., Griebel, G. & Blanchard, R. J. Mouse defensive behaviors: Pharmacological and behavioral assays for anxiety and panic. Neurosci. Biobehav. Rev. 25, 205\u2013218 (2001).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"89011_CR67","first-page":"214","volume":"13","author":"CE Griffin 3rd","year":"2013","unstructured":"Griffin, C. E. 3rd., Kaye, A. M., Bueno, F. R. & Kaye, A. D. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J 13, 214\u2013223 (2013).","journal-title":"Ochsner J"},{"key":"89011_CR68","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00335-011-9356-0","volume":"22","author":"A Duchon","year":"2011","unstructured":"Duchon, A. et al. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: Relevance for modeling Down syndrome. Mamm. Genome 22, 674\u2013684 (2011).","journal-title":"Mamm. Genome"},{"key":"89011_CR69","volume-title":"The Mouse Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos, G., Keith, B. J. & Franklin, M. The Mouse Brain in Stereotaxic Coordinates (Elsevier Science, 2007)."},{"key":"89011_CR70","first-page":"73","volume":"27","author":"RB Billimoria","year":"1981","unstructured":"Billimoria, R. B., Naik, P. R. & Satoskar, R. S. Effect of diazepam alone and in combination with chlorpromazine or propranolol in experimentally induced convulsions in mice. J. Postgrad.Med. 27, 73\u201379 (1981).","journal-title":"J. Postgrad.Med."},{"key":"89011_CR71","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.vascn.2008.06.001","volume":"58","author":"HM Himmel","year":"2008","unstructured":"Himmel, H. M. Safety pharmacology assessment of central nervous system function in juvenile and adult rats: Effects of pharmacological reference compounds. J. Pharmacol. Toxicol. Methods 58, 129\u2013146 (2008).","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"89011_CR72","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780195301069.001.0001","volume-title":"Rhythms of the Brain","author":"G Buzs\u00e1ki","year":"2006","unstructured":"Buzs\u00e1ki, G. Rhythms of the Brain (Oxford University Press, 2006)."},{"key":"89011_CR73","volume-title":"Modern Spectral Estimation: Theory and Application","author":"SM Kay","year":"1988","unstructured":"Kay, S. M. Modern Spectral Estimation: Theory and Application (Prentice-Hall, 1988)."},{"key":"89011_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0006-8993(09)90002-6","volume":"658","author":"GR Gonzalez Burgos","year":"1994","unstructured":"Gonzalez Burgos, G. R., Biali, F. I., Nicola Siri, L. C. & Cardinali, D. P. Effect of gamma-aminobutyric acid on synaptic transmission and long-term potentiation in rat superior cervical ganglion. Brain Res. 658, 1\u20137 (1994).","journal-title":"Brain Res."},{"key":"89011_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/0304-3940(93)90770-L","volume":"149","author":"H Hirai","year":"1993","unstructured":"Hirai, H., Tomita, H. & Okada, Y. Inhibitory effect of GABA (gamma-aminobutyric acid) on the induction of long-term potentiation in guinea pig superior colliculus slices. Neurosci. Lett. 149, 198\u2013200 (1993).","journal-title":"Neurosci. Lett."},{"key":"89011_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(92)90071-9","volume":"49","author":"S del Cerro","year":"1992","unstructured":"del Cerro, S., Jung, M. & Lynch, G. Benzodiazepines block long-term potentiation in slices of hippocampus and piriform cortex. Neuroscience 49, 1\u20136 (1992).","journal-title":"Neuroscience"},{"key":"89011_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0304-3940(98)00178-5","volume":"245","author":"M Higashima","year":"1998","unstructured":"Higashima, M., Kinoshita, H. & Koshino, Y. Differences in the effects of zolpidem and diazepam on recurrent inhibition and long-term potentiation in rat hippocampal slices. Neurosci. Lett. 245, 77\u201380 (1998).","journal-title":"Neurosci. Lett."},{"key":"89011_CR78","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.cell.2011.11.029","volume":"147","author":"PJ Zhu","year":"2011","unstructured":"Zhu, P. J. et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147, 1384\u20131396 (2011).","journal-title":"Cell"},{"key":"89011_CR79","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/2041-210X.12874","volume":"9","author":"A Rodriguez","year":"2018","unstructured":"Rodriguez, A. et al. ToxTrac: A fast and robust software for tracking organisms. Methods Ecol. Evol. 9, 460\u2013464 (2018).","journal-title":"Methods Ecol. Evol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89011-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T05:11:30Z","timestamp":1675228290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89011-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89011"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89011-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"26 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9521"}}